Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kamil A, Sokolowski"'
Autor:
Srilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, Brian W. C. Tse, Kamil A. Sokolowski, Panchadsaram Janaththani, Achala Fernando, Leire Moya, Carson Stephens, Ying Dong, Joan Röhl, Saeid Alinezhad, Ian Vela, Joanna L. Perry-Keene, Katie Buzacott, Robert Nica, The IMPACT Study, Manuela Gago-Dominguez, The PROFILE Study Steering Committee, Johanna Schleutker, Christiane Maier, Kenneth Muir, Catherine M. Tangen, Henrik Gronberg, Nora Pashayan, Demetrius Albanes, Alicja Wolk, Janet L. Stanford, Sonja I. Berndt, Lorelei A. Mucci, Stella Koutros, Olivier Cussenot, Karina Dalsgaard Sorensen, Eli Marie Grindedal, Ruth C. Travis, Christopher A. Haiman, Robert J. MacInnis, Ana Vega, Fredrik Wiklund, David E. Neal, Manolis Kogevinas, Kathryn L. Penney, Børge G. Nordestgaard, Hermann Brenner, Esther M. John, Marija Gamulin, Frank Claessens, Olle Melander, Anders Dahlin, Pär Stattin, Göran Hallmans, Christel Häggström, Robert Johansson, Elin Thysell, Ann-Charlotte Rönn, Weiqiang Li, Nigel Brown, Goce Dimeski, Benjamin Shepherd, Tokhir Dadaev, Mark N. Brook, Amanda B. Spurdle, Ulf-Håkan Stenman, Hannu Koistinen, Zsofia Kote-Jarai, Robert J. Klein, Hans Lilja, Rupert C. Ecker, Rosalind Eeles, The Practical Consortium, The Australian Prostate Cancer BioResource, Judith Clements, Jyotsna Batra
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-21 (2024)
Abstract Genetic variation at the 19q13.3 KLK locus is linked with prostate cancer susceptibility in men. The non-synonymous KLK3 single nucleotide polymorphism (SNP), rs17632542 (c.536 T > C; Ile163Thr-substitution in PSA) is associated with reduced
Externí odkaz:
https://doaj.org/article/8eafcf751cfb463fb1624d18ac08892c
Autor:
Yu Hin Tang, Anja Rockstroh, Kamil A. Sokolowski, Layla-Rose Lynam, Melanie Lehman, Erik W. Thompson, Philip A. Gregory, Colleen C. Nelson, Marianna Volpert, Brett G. Hollier
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-17 (2022)
Abstract Background Triple-negative breast cancers (TNBC) have a relatively poor prognosis and responses to targeted therapies. Between 25 and 39% of TNBCs are claudin-low, a poorly differentiated subtype enriched for mesenchymal, stem cell and mitog
Externí odkaz:
https://doaj.org/article/684155e1b55647e9a6a13d4ab5bc7d5f
Autor:
Sahar Keshvari, Berit Genz, Ngari Teakle, Melanie Caruso, Michelle F. Cestari, Omkar L. Patkar, Brian W. C. Tse, Kamil A. Sokolowski, Hilmar Ebersbach, Julia Jascur, Kelli P. A. MacDonald, Gregory Miller, Grant A. Ramm, Allison R. Pettit, Andrew D. Clouston, Elizabeth E. Powell, David A. Hume, Katharine M. Irvine
Publikováno v:
Disease Models & Mechanisms, Vol 15, Iss 4 (2022)
Resident and recruited macrophages control the development and proliferation of the liver. We have previously shown in multiple species that treatment with a macrophage colony stimulating factor (CSF1)-Fc fusion protein initiated hepatocyte prolifera
Externí odkaz:
https://doaj.org/article/9b4f9a4ccdaa4fd4b6ee2680c8ac5715
Autor:
Mei-Chun Yeh, Brian W. C. Tse, Nicholas L. Fletcher, Zachary H. Houston, Maria Lund, Marianna Volpert, Chelsea Stewart, Kamil A. Sokolowski, Varinder Jeet, Kristofer J. Thurecht, Douglas H. Campbell, Bradley J. Walsh, Colleen C. Nelson, Pamela J. Russell
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract Purpose Chimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth,
Externí odkaz:
https://doaj.org/article/2ef2c8e3d8664d7a8617ef5010ba309f
Autor:
Karla X. Vazquez‐Prada, Shehzahdi S. Moonshi, Yuao Wu, Fahima Akther, Brian W.C. Tse, Kamil A. Sokolowski, Karlheinz Peter, Xiaowei Wang, Gordon Xu, Hang Thu Ta
Publikováno v:
Small. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f038423bc4729a3e9d3d8fa5d862cc9
https://doi.org/10.1002/smll.202370070
https://doi.org/10.1002/smll.202370070
Autor:
Tashbib, Khan, Nicholas J, Lyons, Madeline, Gough, Kayden K X, Kwah, Tahleesa J, Cuda, Cameron E, Snell, Brian W, Tse, Kamil A, Sokolowski, Lesley A, Pearce, Timothy E, Adams, Stephen E, Rose, Simon, Puttick, Marina, Pajic, Mark N, Adams, Yaowu, He, John D, Hooper, Thomas, Kryza
Publikováno v:
Theranostics. 12:6915-6930
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db096fd0daed377767c37a9663ed16a8
https://doi.org/10.7150/thno.78171
https://doi.org/10.7150/thno.78171
Autor:
Sahar Keshvari, Jesse JR Masson, Michelle Ferrari-Cestari, Liviu-Gabriel Bodea, Fathima Nooru-Mohammed, Brian WC Tse, Kamil A. Sokolowski, Lena Batoon, Omkar L. Patkar, Mitchell A. Sullivan, Hilmar Ebersbach, Cian Stutz, Robert G. Parton, Kim M. Summers, Allison R. Pettit, David A. Hume, Katharine Margaret Irvine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893fe280204496ce951c3aa8a37f739b
https://doi.org/10.2139/ssrn.4354093
https://doi.org/10.2139/ssrn.4354093
Publikováno v:
Environmental Earth Sciences. 81
Heritage buildings always pose challenges due to experiencing high temperatures and pressure over time. Sandstone is one of the common sedimentary rock types used for these buildings. Therefore, it is very important to understand the microstructural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d40b421279eceda6e3dbe16f65db3e74
https://doi.org/10.1007/s12665-022-10514-6
https://doi.org/10.1007/s12665-022-10514-6
Autor:
Pamela J. Russell, Bradley J. Walsh, Brian W.C. Tse, Mei-Chun Yeh, Varinder Jeet, Douglas Campbell, Nicholas L. Fletcher, Marianna Volpert, Chelsea Stewart, Maria E. Lund, Kristofer J. Thurecht, Kamil A. Sokolowski, Colleen C. Nelson, Zachary H. Houston
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-13 (2020)
EJNMMI Research
EJNMMI Research
PurposeChimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth, which is o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba38dacb09cb2ec4ef0eabe2e265cd5d
http://link.springer.com/article/10.1186/s13550-020-00637-x
http://link.springer.com/article/10.1186/s13550-020-00637-x
Autor:
Stephen E. Rose, Chao Li, Paul Thomas, James C. Whisstock, Kamil A. Sokolowski, Simon Puttick, T. Cuda, Elena I. Deryugina, James P. Quigley, Cameron Snell, David Wyld, Ashleigh Parkin, Tashbib Khan, Ruby H. P. Law, Thomas Kryza, Marina Pajic, Andrew D. Riddell, Brian W.C. Tse, Madeline Gough, Yaowu He, John D. Hooper, Nicholas Lyons, Andrew Barbour, Julia Yin
Publikováno v:
Theranostics
Background: CUB domain-containing protein 1 (CDCP1) is a cell surface receptor regulating key signalling pathways in malignant cells. CDCP1 has been proposed as a molecular target to abrogate oncogenic signalling pathways and specifically deliver ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410789c01e8cafcde72b853d34fdf094
http://europepmc.org/articles/PMC7086361
http://europepmc.org/articles/PMC7086361